Ceredex Value Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,114,353
Closed -$102M 119
2020
Q2
$102M Buy
1,114,353
+70,845
+7% +$6.4M 1.51% 18
2020
Q1
$82.3M Buy
1,043,508
+82,936
+9% +$6.92M 1.41% 19
2019
Q4
$83.4M Sell
960,572
-24,170
-2% -$2.02M 0.96% 40
2019
Q3
$82.4M Sell
984,742
-141,037
-13% -$12M 0.98% 37
2019
Q2
$94.7M Sell
1,125,779
-80,155
-7% -$6.31M 1.15% 23
2019
Q1
$96.4M Buy
1,205,934
+180,125
+18% +$13.4M 1.18% 20
2018
Q4
$74.2M Sell
1,025,809
-567,317
-36% -$39.9M 1% 37
2018
Q3
$117M Sell
1,593,126
-38,909
-2% -$2.55M 1.31% 12
2018
Q2
$99.5M Buy
1,632,035
+9,274
+0.6% +$562K 1.14% 14
2018
Q1
$97.2M Buy
+1,622,761
New +$97.8M 1.16% 12

Other funds holding ABT

Ceredex Value Advisors's ABT Position: Q3 2020 in Review

Ceredex Value Advisors sold out of Abbott (ABT) in Q3 2020, closing a stake of 1,114,353 shares — an estimated $102M sold.

Ceredex Value Advisors first reported a position in ABT in Q1 2018 and held it in 10 quarters. The position peaked at $117M in Q3 2018. 2,306 funds tracked by Wall St. Rank hold ABT as of Q3 2020.

  • Ceredex Value Advisors reported no remaining Abbott position as of Q3 2020 after selling out during the quarter.
  • Ceredex Value Advisors sold 1,114,353 Abbott shares in Q3 2020, an estimated $102M.
  • Ceredex Value Advisors first reported a position in Abbott in Q1 2018 and held it in 10 quarters.
  • Ceredex Value Advisors's Abbott position peaked at $117M in Q3 2018.
  • 2,306 funds tracked by Wall St. Rank held Abbott as of Q3 2020.

Based on Ceredex Value Advisors's 13F filing for Q3 2020, filed 9 Nov 2020.